| PBPK | Physiologically Based Pharmacokinetic |
| ADME | Absorption Distribution Metabolism Excretion |
| FDA | Food and Drug Administration |
| EMA | European Medicines Agency |
| NASH | Non-Alcoholic Steatohepatitis |
| NAFLD | Non-Alcoholic Fatty Liver Disease |
| PBPK | Physiologically Based Pharmacokinetic |
| ADME | Absorption Distribution Metabolism Excretion |
| FDA | Food and Drug Administration |
| EMA | European Medicines Agency |
| NASH | Non-Alcoholic Steatohepatitis |
| NAFLD | Non-Alcoholic Fatty Liver Disease |